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Histioconductive approaches to soft-tissue defects use scaffolds seeded with lineage- and tissue-speciﬁc
progenitors to generate tissue which should reside in equilibrium with adjacent tissue. Scaffolds guide
histiogenesis by ensuring cell–cell and cell–matrix interactions. Hyaluronic acid-based (HA) pre-
adipocyte-seeded scaffolds were evaluated for their adipo-conductive potential and efﬁcacy in humans.
Preadipocytes were isolated from lipoaspirate material and seeded on HA scaffolds. The cellular bio-
hybrid (ADIPOGRAFT) and an acellular control scaffold (HYAFF11) were implanted subcutaneously. At
speciﬁc time points (2, 8 and 16 weeks) explants were analyzed histopathologically with immunohis-
tochemistry. No adverse tissue effects occurred. Volume loss and consistent degradation of the HYAFF11
scaffolds compared to the ADIPOGRAFT group indicated progressive tissue integration. No consistent
histological differences between both groups were observed. By 8 weeks all void spaces within the
scaffolds were ﬁlled with cells with pronounced matrix deposition in the ADIPOGRAFT bio-hybrids.
Here we show that HA scaffolds were stable cell carriers and had the potential to generate volume-
retaining tissue. However, no adipogenic differentiation was observed within the preadipocyte-seeded
scaffolds.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Engineered adipose tissue could overcome the disadvantages
associated with the implantation of synthetic materials or autolo-
gous soft-tissue grafts. The fascination for adipose tissue as an
autologous substitute to approach tissue deﬁciencies emerges from
its intrinsic characteristics. It not only is available in easily acces-
sible subcutaneous depots but is also very manageable in the way
tissue defects can be structurally moulded to reconstruct the di-
mensions of the lost body contour. Adipose tissue is organized into
a three-dimensional dynamic connective tissue which hosts a
stromal fraction, and a microvascular plexus entwined within
a highly organized extracellular matrix (ECM) [1]. This stromal-
vascular fraction (SVF) consists of a heterogeneous cell population
of which the adipose-derived adult stem (ADAS) cells are of sig-
niﬁcant interest for potential regenerative applications [2]. These
multipotent cells [3] can be harvested through liposuction without
altering their viability [4,5]. The objective in engineering adipose
tissue is to shape a three-dimensional tissue substitute which
prospers by biochemical, physical, and cellular cues andrt).
All rights reserved.approximates the native tissue equivalent. Histioconductive tissue
engineering strategies use additional materials as cell carriers
(scaffolds) to create the shape and dimensions of reparative tissues
and then functionally and molecularly integrate those bio-hybrids
within the surrounding host tissue. Materials that meet funda-
mental requirements such as controlled degradation, cytotoxicity
and immunogenity are needed. Research reports have shown suc-
cessful and reproducible inoculation and culturing of adipocyte-
and preadipocyte-precursor cells (preadipocytes and progenitors,
respectively) on synthetic [6,7] or natural [8] prefabricated scaf-
folds [9] with subsequent differentiation in vitro or adipose tissue
formation in vivo [10]. The scaffolds within these bio-hybrids pro-
vided the seeded cells speciﬁc attachment or binding sites, shaped
the tissue construct and functioned as geometrical environments in
which not only cells received their essential cues for a structural cell
organization and cellular behaviour but also cellular function was
modulated [11,12]. Various scaffold materials have been analyzed
in experiments for autotransplantation as well as for in vitro or
in vivo growth and differentiation of preadipocytes [6,9,13,14] but
no data extrapolations have been realized yet to clinical applica-
tions. In this pilot clinical trial hyaluronic acid-based (HA) scaffolds
(HYAFF11) were used as a cell-carrier material. This naturally
occurring polysaccharide is a major component of the ECM in
connective tissues [15], plays a prominent role in cellular behaviour
Fig. 1. Lipoaspirate was harvested from the lateral abdominal region under local anesthesia (A). Hemi-cylindrical HYAFF11 scaffolds were used as cell carriers and implanted in the
sub-umbilical area (B and C) with the cell-seeded implant located on the left side in a subcutaneous pocket (D). Scaffolds were easy to handle (E). (F) the cell-seeded scaffold in
place.
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saccharide and not a protein it is potentially less antigenic, which is
an important property when considering clinical uses. Its sup-
portive role for precursor cell proliferation and differentiation has
been conﬁrmed by several in vivo and in vitro studies [17].
HYAFF11 is based on hyaluronic acid modiﬁed by esteriﬁcation
which increases the hydrophobicity, the residence time in vivo and
makes it more resistant to hyaluronidase activity. Previous studies
observed the potential to support expansion and differentiation of
adipose precursor cells in vivo [8]. When implanted in nude mice
human preadipocyte-seeded HYAFF11 sponges showed a higher
cell density than collagen constructs after 3 weeks [10]. Halbleib
et al. deﬁned the experimental conditions under which human
adipocyte precursor cells could be effectively inoculated and cul-
tured on HA scaffolds [9] and provided basic evidence that human
preadipocytes can be used to establish adipose tissue engineering
techniques to obtain a three-dimensional soft-tissue ﬁller. Their
appropriate and well-deﬁned porous microarchitecture not only
allowsmorphogenesis but also provides an environment for matrix
deposition and angiogenesis. Based on these promising ﬁndings
and the straightforward clinical ﬂowchart a clinical trial was setup
to evaluate the efﬁciency of those scaffolds in humans in vivo,
mimicking a clinical small-volume tissue deﬁcit.
2. Materials and methods
2.1. Lipoaspirate material
All experimental procedures were approved by the Human Research Ethics
Committee. Twelve volunteers, aged 20–35 years, were included in this trial
according to speciﬁc inclusion criteria (average age¼ 25.5; average BMI¼ 23.5).
Lipoaspirate material was obtained (w5 to 10 cc) through a liposuction procedure
under local anaesthesia (Xylocain 1% without adrenalin) with informed consentthrough the Department of Plastic Surgery of the University Hospital Gent. Lip-
oaspirate material was aspirated through a Coleman ASP I (B¼ 2.5 mm) liposuction
cannula connected to a 10 cc sterile luer-lock disposable syringe. The average as-
pirated fat volume per volunteer was 8.27 cc. Donor sites were the lower lateral
abdominal areas in all cases (Fig. 1A). The sealed luer-lock syringes containing the
lipoaspirate were stored in a cooled foamy kit.
2.2. Isolation of human adipose stromal cells
The fat tissue samples were immediately dispatched to Fidia Advanced Bio-
polymers (FAB) Laboratories (Abano Terme, Italy) for further processing. All samples
arrived within 24 h. Lipoaspirate material waswashed three times with PBS (vol:vol,
1:1) and digested at 37 C with a sterile ﬁltered collagenase solution (collagenase
Type I 500 U/ml, 8% FCS, 0.02 M HEPES and 0.02 IU–0.02 mg/ml penicillin/strepto-
mycin in Dulbecco’s modiﬁed eagle medium/Ham’s F-12) (vol:vol, 1:1) for 1 h. Prior
experiments have demonstrated a cell concentration recovery of 0.15–
0.2106 cells/cc of fat after collagenase digestion. The yield of preadipocyte cells
from 1 g adipose tissue was in the range of 2–3105 cells of which not more than
78% attached to the scaffolds [9]. As 5–8 ml of lipoaspirate was digested, the number
of cells recovered was in the range of 0.75–1.6106. After centrifugation (200g for
10 min at 17 C) and removal of the supernatant, cells were resuspended in a pre-
adipocyte culture medium (DMEM/Ham’s F-12 supplemented with 10% FCS, 1 nM
basic ﬁbroblast growth factor (bFGF), 0.02 IU–0.02 mg/ml penicillin/streptomycin)
to obtain a ﬁnal volume of w100 to 200 ml. Cells isolated by all samples differenti-
ated into mature adipocytes after 1 week of culture in differentiation medium.
2.3. Characteristics of the scaffolds
HYAFF11 scaffolds were provided by Fidia Advanced Biopolymers s.r.l. (FAB,
Abano, Italy) (Fig. 1B). HYAFF11 is a linear derivative of hyaluronic acid modiﬁed by
complete esteriﬁcation of the carboxylic function of glucuronic acid with benzyl
groups [18]. HYAFF11 biomaterial is spontaneously degraded and resorbed. The
structure of the sponges used in this trial showed open, interconnecting pores with
pore size of 400 mm. HYAFF11 sponges with a pore size of 400 mm appeared to be
superior to other scaffold types regarding cell attachment rate [9]. HYAFF11 scaf-
folds were prepared as semi-cylindrical disks with a diameter of 10 mm and a height
of 4 mm and were sterilized by g-radiation.
Fig. 2. Follow-up visits of the volunteers were performed and the scaffolds could be palpated easily on clinical examination (A). (B) a intraoperative view on the subcutaneously
implanted ADIPOGRAFT scaffold which could be retrieved easily. (C) the explanted ADIPOGRAFT scaffold at 16 weeks which maintained the original dimension and volume.
Section of the ADIPOGRAFT scaffold revealed the appearance of a tissue-like substance which ﬁlled/replaced the complete scaffold. The arrow indicates a small centre of the
scaffold with the absence of the tissue-like substance in which part of the hyaluronic acid material could be retrieved.
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The hemi-cylindrical HYAFF11 sponges were hydrated for 24 h at 37 C in an
atmosphere of 5% CO2 and 95% humidity. Sponges were then washed three times
with 10 ml of DMEM/Ham’s F-12 medium supplemented with 10% FCS. Sponges
were ﬁnally dried out using a disposable pipette connected to vacuum [19].
2.5. Cell inoculation of the scaffolds
Cell seeding was performed by moving the cell-suspension containing pipette
across the entire surface of the sponge [9]. Considering a 10% cell loss during the
seeding procedure (evaluated during experiments on cell seeding efﬁciency), the
number of cells seeded on each semi-cylindrical ADIPOGRAFT scaffold ranged
between 0.67106 and 1.4106. The cell-seeded hemi-cylindrical HYAFF11
sponge was called ADIPOGRAFT. Seeded and non-seeded HYAFF11 sponges were
incubated and supplied with a preadipocyte culture medium 3 h after incubation
with fresh medium changed (DMEM/Ham’s F-12 medium supplemented with 10%
FCS) after 24 h. Sponges were washed three times with sterile phosphate buffered
saline 48 h later and stored in an appropriate vacuum sealed double sterile package
ready for transport. Before packaging a LAL test was performed on the medium
submerging the sponges to check for bacterial endotoxins.
2.6. Implantation and ﬂowchart
Four days after the initial liposuction the ADIPOGRAFT bio-hybrid and an
acellular control HYAFF11 scaffold were implanted under local anaesthesia (Xylo-
cain 1% without adrenalin) (Fig. 1C–F). The skin was disinfected with chlorhexidin
aqua 0.5% (pharmacy UZ Gent). Through a 1 cm median sub-umbilical skin incision
two paramedian subcutaneous pockets were created by blunt dissection (1.5 cm by
1 cm) (Fig. 1). Seeded and non-seeded sponges were unpacked and immediately
implanted taking care to avoid any trauma to their fragile consistency. Implants
were not weighed before implantation. The ADIPOGRAFT bio-hybrid was
implanted in the right subcutaneous pocket while the control HYAFF11 scaffold
was positioned in the left subcutaneous pocket (Fig. 2). The incisionwas closed with
subdermal sterile absorbable subcutaneous 5-0 sutures (Ethicon) and a running
intracuticular non-resorbable 6-0 suture (Ethicon).
2.7. Time courses, follow-up and harvest
Three time courses (2 (T1), 8 (T2) and 16 (T3) weeks) were conducted for each
group consisting of four volunteers which were followed on a weekly outpatient
basis. In the 16 weeks’ group one volunteer ultimately decided not to be includedin the trial. He was not replaced as the recruitment process was already ﬁnalized.
At the speciﬁc time points the tissue specimens were harvested under local
anaesthesia through the same initial incision (Fig. 3). Careful dissection excised
a margin of surrounding fat tissue to ensure complete removal of the scaffolds
which were easily identiﬁed intraoperatively. Specimens were not weighed due
to the presence of a variable amount of native and ﬁbrotic tissue which could
interfere with the ﬁnal weight. The harvested tissue specimens were embedded in
phosphate buffered saline. Thin sections (4 mm) were cut using polycut sectioning.
Sections were stained with haematoxylin and eosin, Van Geison viewed by light
microscopy (Zeiss).
3. Results
3.1. Clinical follow-up
All surgical procedures were completely successful and un-
eventful and during the entire postoperative follow-up there were
no adverse effects observed with the implants, both for cell-seeded
and unseeded scaffolds. Implantation sites in all experimental
groups showed no signs of wound dehiscence, scar contracture or
scaffold migration. Scaffolds were not visible at clinical inspection
but clinical examination revealed palpable margins of all cell-
seeded scaffolds in all groups and the T1 control group (2 weeks)
(Fig. 2A). HYAFF11 control scaffolds in T2 and T3 were non-pal-
pable indicating progressive scaffold degradation. This is consistent
with ﬁndings of other investigators [19]. However, during follow-
up the overlying subdermal and dermal tissues showed no
depression with good preserved skin quality in all groups. The
scaffolds in the cell-seeded group felt moderately soft while
non-seeded scaffolds in general appeared to disintegrate during
follow-up, in particular in the 8 and 16 weeks’ group.
3.2. Macroscopy
At the selected time points the scaffolds were harvested from
the subcutaneous pouches in the infra-umbilical area. Fig. 2B
Fig. 3. H¼HYAFF11 control scaffold; A¼ ADIPOGRAFT cell-seeded scaffold; T1: 2 weeks (H1a – Von Kossa, H1b – Van Geison, A1a – H&E, A1b – Van Geison): there was incomplete
cellular inﬁltration by inﬂammatory cells, which were well dispersed throughout the scaffold in a loose ﬁbrous collagenous extracellular matrix network. Some giant cell formation
(arrows in A1b) was observed within scaffolds, but there was no evidence of mature adipocytes. T2: 8 weeks (H2a – Von Kossa, H2b – Van Geison, A2a – Van Geison, A2b – H&E): there
was extensive inﬁltration of inﬂammatory cells within the scaffolds and giant cell formation. At the periphery of the scaffold a thin ﬁbrous capsula was present in some but not all
interface areas where this was present it formed a clear demarcation between the host tissue and the scaffold. In ADIPOGRAFT samples at 8 weeks, vascularisation (arrow) was
observed throughout the scaffold (S) which was separated from the native fat tissue (FT) by a thin capsula (C). T3: 16 weeks (Van Geison): non-seeded HYAFF11 explants (H3a)
indicated degeneration of the scaffold and complete cellular inﬁltration by inﬂammatory cells which were well dispersed throughout the scaffold in a dense ﬁbrous collagenous
extracellular matrix (arrow). Capsular structures were observed around the scaffold (C) with vascular structures (arrow) but without penetration of the latter within the scaffold (S)
(H3b). A moderate organized capsula (C) surrounded the ADIPOGRAFT scaffold (S) at 16 weeks (A3b). Native host fat tissue (FT) was observed outside the capsular structure
without evidence of any mature adipocytes within the scaffold. The ADIPOGRAFT samples showed progressive replacement of the original scaffold by a dense cellular matrix but
without evidence of the presence of mature adipocytes. Pore size decreased dramatically within this group.
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Note the thin capsule formation around the scaffold with good
integration in the surrounding host tissue. The volume of the
scaffold was maintained with the diameter being 10 mm, as origi-
nally fabricated (Fig. 2C). A cross-section of the engineered tissue
construct revealed a pale appearance of the tissue within the
scaffold (Fig. 2D). All ADIPOGRAFT scaffolds were retrieved easily
in each time group and maintained their original shape and di-
mension. Interestingly, the HYAFF11 explants showed consistent
volume loss with degradation of the scaffold into a ‘‘gel-like’’ sub-
stance, in particular in the 8 (T2) and 16 (T3) weeks’ group. In the 16
weeks’ group two HYAFF11 scaffolds were not detectable at har-
vest. Thus, macroscopic examination qualitatively revealed that
cell-seeded scaffolds contributed to the shape and dimension
maintenance of the bio-hybrids.
The representative ADIPOGRAFT scaffolds not only main-
tained their original volume and dimension but also demonstrated
the presence of a tissue-like substance within the scaffold, sug-
gesting that a substantial amount of extracellular matrix or adi-
pose-like tissue had been synthesized in the cell-seeded scaffolds.
Quantiﬁcation of the diameters of in vivo harvested ADIPOGRAFT
and HYAFF11 scaffolds conﬁrmed that the latter shrunk and
almost completely lost their original dimensions. Cell-seeded
scaffolds were signiﬁcantly bigger than corresponding acellular
scaffolds.
3.3. Histological features
Cell-free scaffolds stained with haematoxylin and eosin, Von
Kossa and Van Geison demonstrated the invasion of cells within the
scaffold (Fig. 3). Cell inﬁltrationwas initially incomplete at 2 weeks.
HYAFF11 scaffolds demonstrated both cell dense and cell sparse
areas in an intact scaffold matrix (Fig. 3, H1a). There was no evi-
dence of mature adipocytes present within or at the periphery of
the HYAFF11 scaffold in all groups. By 8weeks all void spaces were
ﬁlled with cells or extracellular matrix. At 16 weeks the control
scaffolds showed the replacement of the HYAFF11 material by
a signiﬁcant and dense ﬁbrous collagenous ECM network (Fig. 3,
H3a) with scaffold material still intact. Over time, the overall pore
size diameter decreased signiﬁcantly due to the increasing de-
position of a dense interconnecting ECM and the population of
inﬂammatory cells becoming well established throughout the
scaffold. Few vascular structures and no calciﬁcationwere observed
within the acellular scaffolds. Capsula formation was observed
which became well vascularised at 16 weeks (Fig. 3, H3b). Despite
a well developed vascular plexus within the ﬁbrotic capsula there
seemed to be little or no neo-vessel formation at the periphery or
within the non-seeded scaffold. ADIPOGRAFT  explants stained
with haematoxylin and eosin, Von Kossa and Van Geison demon-
strated increased collagen deposition compared to the control
scaffolds (Fig. 3, A3a). An incomplete cellular population was ob-
served with cells well dispersed throughout the scaffold but in
greater numbers compared to the HYAFF11 control scaffolds.
There was an increase in inﬂammatory granulation in some areas
within the scaffold which were still maintained in a ﬁbrous extra-
cellular matrix network. Margins and signiﬁcant areas inside scaf-
fold demonstrated inﬂammatory cell inﬁltration. In ADIPOGRAFT
explants at 2 and 8 weeks vascular structures (Fig. 3, A1b and A2b)
were noticeable at the periphery of the scaffold. Few vascular
structures were observed in the deeper layers of the ADIPOGRAFT
samples. There was a discrete capsula formation (Fig. 3, A2b and
A3b) which distinctively separated the scaffold from the sur-
rounding native fat tissue. The original scaffold within this group
underwent an increased rate of degradation compared to the non-
seeded group. Despite some distinctive differences between the
experimental and control groups no mature adipocytes wereindicated within the ADIPOGRAFT explants. Cellularity was higher
in all cell-loaded scaffolds compared to the non-seeded control
groups. Pore diameters differed after 8 weeks of implantation with
a continuous decrease in pore size which was prominent in the 16
weeks cell-loaded group.
4. Discussion
A tissue engineering approach that uses implantable pre-
adipocyte-seeded natural or synthetic polymer scaffolds should
result in a living adipo-inductive substitute, which could overcome
current disadvantages of autograft and allogenic volume sub-
stitutes. The availability of progenitors within the adipose stromal
fraction for building desired neo-tissue types and the un-
derstanding of vectors that govern their differentiation emerge as
important factors for successful neo-tissue construction [20]. Tissue
engineering research uses regenerative protocols that involve the
engineered recapitulation of certain embryonic events [21] that
coordinate the morphogenesis of the targeted tissue. The extra-
cellular matrix (ECM) is recognized as a highly hydrated network
which comprises several main effectors [22–24]. Its architecture
provides not only an instructive cue for the conversion and spatial
orientation [25] of precursor cells into a functional tissue [26] but
also properties at a macroscale level provide a number of tissue
functions including osmosis, molecular and nutrient transport
[12,27]. A central event in adipogenesis is the active remodelling of
the ECM [28]. Biodegradable scaffolds designed to meet tissue en-
gineering purposes mimic the in vivo three-dimensional extracel-
lular microarchitecture to provide precursors the signals to develop
in desirable phenotypes, themeans for cell expansion and the space
for the newly deposited ECM to achieve properties similar to those
of the native tissue [1,29]. Scaffolds have been widely used for
regenerating tissues [15,30]. The open, porous structure acts as
a preserver of space for efﬁcient cellular adhesion and seeding and
facilitates vessel ingrowth with subsequent mass transport of ox-
ygen and nutrients. The three-dimensional geometry of the native
ECM constrains cells during regeneration and provides space for
tissue development [25] and in vitro studies have shown that the
scaffold geometry promotes preadipocyte differentiation [31]. The
architecture of adipose tissue has been reconstructed using adi-
pose-derived stromal cells seeded onto different scaffold materials
[6–8,13,14]. Hyaluronic acid-based scaffolds have been used clini-
cally to successfully direct chondrocyte development [32–34]. The
nonantigenic hyaluronic acid molecule is a prominent interstitial
protein in the ECM. It plays a prominent role in cellular function
and behaviour, tissue viscosity and osmosis and fulﬁls an important
mechanical role in shock absorption and space ﬁlling [35–37].
Previous studies showed that HYAFF11 scaffolds with a pore size
diameter of 400 mm were suitable environments for adipocyte
precursor cell seeding with subsequent proliferation and differen-
tiation [9]. Controlled or predictable scaffold resorption is a crucial
requirement when considering histioconductive approaches for
organogenesis. Besides a good initial mechanical stability the
acellular HYAFF11 scaffolds in this trial showed a progressive
degradation rate with pore size reduction over time with a gradual
deposition of a newly formed ECM. The non-inﬂammatory
defragmentation process resulted in the formation of a gel-like
substance noted macroscopically at harvest. Two HYAFF11 scaf-
folds were completely disintegrated at 16 weeks. They lacked cy-
totoxicity and promoted the invasion of an aspeciﬁc cell population
with no elicitation of an immune or inﬂammatory response in-
dicating their compatibility with the physiological host conditions
[16]. The gross shape and volume of the cellular ADIPOGRAFT
scaffolds were maintained indicating that HA scaffolds do have the
potential to act as anchor sites and preservers of space for cells to
develop into multicellular communities which resulted in the
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Cellularity with pronounced ECM deposition was higher in all cell-
loaded scaffolds compared to the non-seeded control groups con-
sistent with previous ﬁndings in rodents [19]. This ﬁnding was
prominent from 8 weeks on and increased in the 16 weeks’ group.
In contrast to previous ﬁndings in rodents, no differentiated adi-
pocytes were observed within the sponges. Organogenesis requires
a fortiori the presence of a functional vascular network and the
disadvantage of cell-based tissue engineering strategies is that the
seeded cell population in implanted bio-hybrids will be located
more than 100 mm away from the native microvasculature which is
the diffusion limit for oxygen. Migration and proliferation of qui-
escent endothelial cells from pre-existing vessels – a process called
angiogenesis [38] – will only occur in a later stage to establish
a nourishing vascular plexus. A xenograft study showed that hu-
man preadipocyte-seeded HA scaffolds were indeed revascularized
with integrated vessels in almost all layers of the sponge with
preadipocytes being well distributed over the cross-section of the
implanted sponge [19]. Despite the fact that oligomers, the degra-
dation fragments of hyaluronic acid, act on angiogenesis [39] and
that preadipocytes have a lower oxygen consumption and higher
tolerance for survival than mature fat cells [40] the major disad-
vantage of cell-based strategies is that the pre-cultured tissue
constructs, which must become vascularised once implanted
within the recipient, may not be as successful as methods which
foster a primary neovascularisation of a biological matrix or scaffold
[41]. Embryological adipose tissue formation is preceded by the
establishment of a primary vascular plexus, also called the ‘‘prim-
itive fat organ’’, and further development of adult adipose tissue is
associated with a concomitant increase in the microcirculatory
network. It shows how the interplay between adipocytes and their
vascular compartment characterizes its homeostatic dynamism. In
this human trial, no neo-capillary in-growth was observed within
the cellular or acellular sponges.5. Conclusion
Hyaluronic acid-based scaffolds were demonstrated to be suit-
able materials for soft-tissue regeneration; they maintained vol-
ume when seeded with preadipocytes. The material had
a progressive rate of biodegradation, lacked cytotoxicity and did not
induce a systemic immune response or chronic inﬂammation in
this human in vivo model. Although various materials have been
tested for the potential construction of adipo-scaffolds, major
challenges remain in facilitating adipogenic cell attachment, mi-
gration, and formation of natural adipose matrix in three-di-
mensional biomaterials. Despite promising results in rodents and
excellent biocompatibility and degradation characteristics, HA
scaffolds do not support preadipocyte survival and are not in-
ductive towards adipose tissue formation. The observed volume
maintenance and tissue integration are promising but the deﬁcient
angiogenic penetration which may compromise further tissue
stabilisation requires further development to assess whether this
histioconductive strategy can be used in future soft-tissue aug-
mentation procedures.Acknowledgements
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